# DYANAVEL XR

NDC: 24478-110
Generic name: amphetamine
Labeler / Manufacturer: NextWave Pharmaceuticals, Inc
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: TABLET, EXTENDED RELEASE
Routes: ORAL
Marketing started: 20211104

FDA application: NDA210526

## Active ingredients

- AMPHETAMINE: 20 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"24478-110"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=24478-110
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=ae304b29-0b40-40ec-ad0d-76b742d4a9b9